PapersPMID:29330660
Theobromine consumption does not improve fasting and postprandial vascular function in overweight and obese subjects.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“In the fasting condition, theobromine consumption did not change FMD, brachial artery diameter, and RHI.”
- Study
- crossover
- Duration
- 4 weeks
- Dose studied
- 500 mg theobromine per day in a 20 mL drink at breakfast for 4 weeks, versus placebo drink, crossover with 4-week washout
- Population
- Overweight and obese men and women aged 45-70 years with HDL-C below the 50th percentile of the Dutch population; fasting measurement after 4 weeks of each treatment period
Study record
- Design
- crossover trial
- Species
- human
- Population
- Healthy overweight or slightly obese men and women with low HDL-C
- Participants
- 44
- Comparator
- placebo
- Duration
- 28 days
- Endpoints measured
- 29